DrugPatentWatch Database Preview
Denmark Supplementary Protection Certificates
» See Plans and Pricing
Supplementary Protection Certificates
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1761540 | CR 2017 00007 | Denmark | PRODUCT NAME: IDELALISIB ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/14/938 20140919 | Start Trial |
European Patent Office | 1506211 | CA 2013 00019 | Denmark | Start Trial | |
European Patent Office | 1666481 | CA 2017 00035 | Denmark | PRODUCT NAME: TOFACITINIB, EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT, HERUNDER CITRAT-SALTET; REG. NO/DATE: EU/1/17/1178/001-003 20170324 | Start Trial |
European Patent Office | 2368890 | CR 2015 00015 | Denmark | PRODUCT NAME: OMBITASVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEROF; REG. NO/DATE: EU/1/14/982 20150119 | Start Trial |
European Patent Office | 1586571 | CA 2014 00011 | Denmark | PRODUCT NAME: ALOGLIPTIN; REG. NO/DATE: EU/1/13/844/001-027 20130919 | Start Trial |
European Patent Office | 2822953 | CR 2019 00041 | Denmark | PRODUCT NAME: LORLATINIB ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/19/1355 20190508 | Start Trial |
European Patent Office | 1934174 | CA 2016 00021 | Denmark | PRODUCT NAME: COBIMETINIB, EVENTUELT I EN HVILKEN SOM HELST FORM BESKYTTET AF GRUNDPATENTET, DER INDBEFATTER FARMACEUTISK ACCEPTABLE SALTE OG SOLVATER, SAERLIGT COBIMETINIB HEMIFUMARAT; REG. NO/DATE: EU/1/15/1048 20151124 | Start Trial |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |